XMAG vs MAGS: Betting Against or All-In on Magnificent 7
In 2026, XMAG has surged while MAGS has slipped, underscoring a shift from mega-cap AI bets to broad-market exposure....
Looking to earn more? Discover simple ways to integrate money-making activities into your daily routine.
27,728 articlesIn 2026, XMAG has surged while MAGS has slipped, underscoring a shift from mega-cap AI bets to broad-market exposure....
A senior macro investor warns that the global order is entering a perilous stage of the Big Cycle, likely to test mar...
Investors now have dedicated ETFs to take sides on the Magnificent Seven debate, including concentrated exposure via ...
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Many investors sit on cash waiting for rates to fall. This guide shows why stopping the wait and locking in 4% on new...
A rare misfire during a live-fire demonstration over Camp Pendleton unleashed shrapnel on California's I-5. The Marin...
While Nvidia grabs the spotlight with GPUs, Broadcom quietly powers AI at scale with custom accelerators. This articl...
A major fund just increased its stake in Molina Healthcare, while the stock trades lower. This guide breaks down what...
A new Morgan Stanley Research report argues that housing affordability unlikely return to pre-2022 levels as rates st...
When markets wobble, income-focused investors flock to high-yield ETFs. This piece dives into why the JPMorgan Equity...
Alix Earle launches Reale Actives, a skincare line built for acne-prone skin, marking her move from viral creator to ...
Meta Platforms sits at a critical crossroads: its massive user network is powerful, but an ambitious AI data-center s...